A study on antigenicity and receptor-binding ability of fragment 450-650 of the spike protein of SARS coronavirus

Virology

Volumn 359, Issue 2, 2007, Pages 362-370

  Zhao, Jincun ^a   Wang, Wei ^a   Yuan, Zhihong ^a   Jia, Rujing ^a   Zhao, Zhendong ^a   Xu, Xiaojun ^a   Lv, Ping ^a   Zhang, Yan ^a   Jiang, Chengyu ^b   Gao, Xiao Ming ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

B cell epitope; Receptor binding motif; S protein; SARS CoV

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE 2; EPITOPE; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; UNCLASSIFIED DRUG; VIRUS SPIKE PROTEIN;

ADOLESCENT; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN RECOGNITION; ANTIGENICITY; ARTICLE; B LYMPHOCYTE; BAGG ALBINO MOUSE; BETA SHEET; BINDING AFFINITY; CELL LYSATE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FOLDING; RECEPTOR BINDING; SARS CORONAVIRUS; VERO CELL; VIRUS INFECTIVITY; VIRUS NEUTRALIZATION;

ANIMALS; ANTIBODIES, VIRAL; ANTIBODY AFFINITY; CELL LINE; CERCOPITHECUS AETHIOPS; EPITOPES, B-LYMPHOCYTE; FEMALE; GENE EXPRESSION REGULATION, VIRAL; HUMANS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MODELS, MOLECULAR; PEPTIDYL-DIPEPTIDASE A; PROTEIN CONFORMATION; RECEPTORS, VIRUS; SARS VIRUS; VERO CELLS; VIRAL ENVELOPE PROTEINS;

MUS; SARS CORONAVIRUS;

EID: 33847041926     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.09.022     Document Type: Article

References (26)

1. Chen Z., Pei D., Jiang L., Song Y., Wang J., Wang H., Zhou D., Zhai J., Du Z., Li B., Qiu M., Han Y., Guo Z., and Yang R. Antigenicity analysis of different regions of the severe acute respiratory syndrome coronavirus nucleocapsid protein. Clin. Chem. 50 6 (2004) 988-995
2. Gerdes H.H., and Kaether C. Green fluorescent protein: applications in cell biology. FEBS Lett. 389 1 (1996) 44-47
3. He Y., Zhou Y., Liu S., Kou Z., Li W., Farzan M., and Jiang S. Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine. Biochem. Biophys. Res. Commun. 324 2 (2004) 773-781
4. He Y., Lu H., Siddiqui P., Zhou Y., and Jiang S. Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies. J. Immunol. 174 8 (2005) 4908-4915
5. Ho T.Y., Wu S.L., Cheng S.E., Wei Y.C., Huang S.P., and Hsiang C.Y. Antigenicity and receptor-binding ability of recombinant SARS coronavirus spike protein. Biochem. Biophys. Res. Commun. 313 4 (2004) 938-947
6. Hu H., Li L., Kao R.Y., Kou B., Wang Z., Zhang L., Zhang H., Hao Z., Tsui W.H., Ni A., Cui L., Fan B., Guo F., Rao S., Jiang C., Li Q., Sun M., He W., and Liu G. Screening and identification of linear B-cell epitopes and entry-blocking peptide of severe acute respiratory syndrome (SARS)-associated coronavirus using synthetic overlapping peptide library. J. Comb. Chem. 7 5 (2005) 648-656
7. Hua R., Zhou Y., Wang Y., Hua Y., and Tong G. Identification of two antigenic epitopes on SARS-CoV spike protein. Biochem. Biophys. Res. Commun. 319 3 (2004) 929-935
8. Hua R.H., Wang Y.F., Bu Z.G., Zhou Y.J., Ge J.Y., Wang X.J., and Tong G.Z. Identification and antigenic epitope mapping of immunodominant region amino residues 510 to 672 on the spike protein of the severe acute respiratory syndrome coronavirus. DNA Cell Biol. 24 8 (2005) 503-509
9. Kuba K., Imai Y., Rao S., Gao H., Guo F., Guan B., Huan Y., Yang P., Zhang Y., Deng W., Bao L., Zhang B., Liu G., Wang Z., Chappell M., Liu Y., Zheng D., Leibbrandt A., Wada T., Slutsky A.S., Liu D., Qin C., Jiang C., and Penninger J.M. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat. Med. 11 8 (2005) 875-879
10. Li W., Moore M.J., Vasilieva N., Sui J., Wong S.K., Berne M.A., Somasundaran M., Sullivan J.L., Luzuriaga K., Greenough T.C., Choe H., and Farzan M. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426 6965 (2003) 450-454
11. Li F., Li W., Farzan M., and Harrison S.C. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science 309 5742 (2005) 1864-1868
12. Liu Z., Wang Z., and Chen Y.H. Predefined spacers between epitopes on a recombinant epitope-peptide impacted epitope-specific antibody response. Immunol. Lett. 97 1 (2005) 41-45
13. Lu W., Wu X.D., Shi M.D., Yang R.F., He Y.Y., Bian C., Shi T.L., Yang S., Zhu X.L., Jiang W.H., Li Y.X., Yan L.C., Ji Y.Y., Lin Y., Lin G.M., Tian L., Wang J., Wang H.X., Xie Y.H., Pei G., Wu J.R., and Sun B. Synthetic peptides derived from SARS coronavirus S protein with diagnostic and therapeutic potential. FEBS Lett. 579 10 (2005) 2130-2136
14. Marra M.A., Jones S.J., Astell C.R., Holt R.A., Brooks-Wilson A., Butterfield Y.S., Khattra J., Asano J.K., Barber S.A., Chan S.Y., Cloutier A., Coughlin S.M., Freeman D., Girn N., Griffith O.L., Leach S.R., Mayo M., McDonald H., Montgomery S.B., Pandoh P.K., Petrescu A.S., Robertson A.G., Schein J.E., Siddiqui A., Smailus D.E., Stott J.M., Yang G.S., Plummer F., Andonov A., Artsob H., Bastien N., Bernard K., Booth T.F., Bowness D., Czub M., Drebot M., Fernando L., Flick R., Garbutt M., Gray M., Grolla A., Jones S., Feldmann H., Meyers A., Kabani A., Li Y., Normand S., Stroher U., Tipples G.A., Tyler S., Vogrig R., Ward D., Watson B., Brunham R.C., Krajden M., Petric M., Skowronski D.M., Upton C., and Roper R.L. The Genome sequence of the SARS-associated coronavirus. Science 300 5624 (2003) 1399-1404
15. Nardella C., Lahm A., Pallaoro M., Brunetti M., Vannini A., and Steinkuhler C. Mechanism of activation of human heparanase investigated by protein engineering. Biochemistry 43 7 (2004) 1862-1873
16. Nie Y., Wang G., Shi X., Zhang H., Qiu Y., He Z., Wang W., Lian G., Yin X., Du L., Ren L., Wang J., He X., Li T., Deng H., and Ding M. Neutralizing antibodies in patients with severe acute respiratory syndrome-associated coronavirus infection. J. Infect. Dis. 190 6 (2004) 1119-1126
17. Peiris J.S., Lai S.T., Poon L.L., Guan Y., Yam L.Y., Lim W., Nicholls J., Yee W.K., Yan W.W., Cheung M.T., Cheng V.C., Chan K.H., Tsang D.N., Yung R.W., Ng T.K., and Yuen K.Y. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361 9366 (2003) 1319-1325
18. Rota P.A., Oberste M.S., Monroe S.S., Nix W.A., Campagnoli R., Icenogle J.P., Penaranda S., Bankamp B., Maher K., Chen M.H., Tong S., Tamin A., Lowe L., Frace M., DeRisi J.L., Chen Q., Wang D., Erdman D.D., Peret T.C., Burns C., Ksiazek T.G., Rollin P.E., Sanchez A., Liffick S., Holloway B., Limor J., McCaustland K., Olsen-Rasmussen M., Fouchier R., Gunther S., Osterhaus A.D., Drosten C., Pallansch M.A., Anderson L.J., and Bellini W.J. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 300 5624 (2003) 1394-1399
19. Spiga O., Bernini A., Ciutti A., Chiellini S., Menciassi N., Finetti F., Causarono V., Anselmi F., Prischi F., and Niccolai N. Molecular modelling of S1 and S2 subunits of SARS coronavirus spike glycoprotein. Biochem. Biophys. Res. Commun. 310 1 (2003) 78-83
20. Sui J., Li W., Murakami A., Tamin A., Matthews L.J., Wong S.K., Moore M.J., Tallarico A.S., Olurinde M., Choe H., Anderson L.J., Bellini W.J., Farzan M., and Marasco W.A. Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association. Proc. Natl. Acad. Sci. U.S.A. 101 8 (2004) 2536-2541
21. Wang J., Wen J., Li J., Yin J., Zhu Q., Wang H., Yang Y., Qin E., You B., Li W., Li X., Huang S., Yang R., Zhang X., Yang L., Zhang T., Yin Y., Cui X., Tang X., Wang L., He B., Ma L., Lei T., Zeng C., Fang J., Yu J., Wang J., Yang H., West M.B., Bhatnagar A., Lu Y., Xu N., and Liu S. Assessment of immunoreactive synthetic peptides from the structural proteins of severe acute respiratory syndrome coronavirus. Clin. Chem. 49 12 (2003) 1989-1996
22. Wong S.K., Li W., Moore M.J., Choe H., and Farzan M. A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2. J. Biol. Chem. 279 5 (2004) 3197-3201
23. Xiao X., Feng Y., Chakraborti S., and Dimitrov D.S. Oligomerization of the SARS-CoV S glycoprotein: dimerization of the N-terminus and trimerization of the ectodomain. Biochem. Biophys. Res. Commun. 322 1 (2004) 93-99
24. Zhang H., Wang G., Li J., Nie Y., Shi X., Lian G., Wang W., Yin X., Zhao Y., Qu X., Ding M., and Deng H. Identification of an antigenic determinant on the S2 domain of the severe acute respiratory syndrome coronavirus spike glycoprotein capable of inducing neutralizing antibodies. J. Virol. 78 13 (2004) 6938-6945
25. Zhao J., Wang W., Wang G.F., Li Y., Zhuang H., Xu X., Ren F., Zhao Z., and Gao X.M. Development and evaluation of an enzyme-linked immunosorbent assay for detection of antibodies against the spike protein of SARS-coronavirus. J. Clin. Virol. 33 1 (2005) 12-18
26. Zhao J.C., Zhao Z.D., Wang W., and Gao X.M. Prokaryotic expression, refolding, and purification of fragment 450-650 of the spike protein of SARS-coronavirus. Protein Expr. Purif. 39 2 (2005) 169-174